Tolerance of Concurrent Adjuvant Radiation Therapy and Pembrolizumab for Triple Negative Breast Cancer: Real Life Experience.
Tison T, Loap P, Arnaud E, Cao K, Bringer S, Kissel M, Maaradji S, Mainguene J, Pierga JY, Lerebours F, Vincent-Salomon A, Mirabelle M, Bidard FC, Loirat D, Kirova YM.
Tison T, et al. Among authors: loap p.
Adv Radiat Oncol. 2023 Oct 17;9(3):101384. doi: 10.1016/j.adro.2023.101384. eCollection 2024 Mar.
Adv Radiat Oncol. 2023.
PMID: 38495034
Free PMC article.